Latest Safety News

Page 56 of 146
InhaleRx has secured ethics approval to begin a Phase 1 clinical trial of IRX-616a, a synthetic cannabidiol inhaler aimed at providing fast relief for panic disorder. The fully funded study will assess safety and pharmacokinetics in healthy volunteers.
Ada Torres
Ada Torres
28 Aug 2025
SPC Global Holdings Ltd has reported FY25 proforma results exceeding guidance with a normalised EBITDA of $30.3 million, setting the stage for ambitious growth and international expansion in FY26.
Victor Sage
Victor Sage
28 Aug 2025
Clinuvel Pharmaceuticals reports steady financial growth with an 8% rise in revenue and 2% profit increase, while expanding its US commercial footprint and completing recruitment for a pivotal vitiligo trial.
Ada Torres
Ada Torres
28 Aug 2025
Austral Gold Limited reported a net loss of US$1.3 million for the first half of 2025, while completing refurbishment of its Casposo plant to diversify production. Despite operational challenges and increased costs, the company leans on shareholder support and strategic investments to manage liquidity pressures.
Maxwell Dee
Maxwell Dee
28 Aug 2025
RPM Automotive Group Ltd reported steady FY25 results with improved margins despite a slight revenue dip, while outlining strategic growth and tyre recycling expansion plans for FY26.
Victor Sage
Victor Sage
28 Aug 2025
X2M Connect reports a 43% revenue decline in FY25 but improves gross margins and expands into the Middle East and renewable energy sectors, setting a positive outlook for FY26.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Greatland Resources Limited has reported a robust unaudited FY2025 result, generating $337.3 million net profit after tax from seven months of Telfer gold-copper mine operations, alongside a successful ASX listing and strong cash flow.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Lynas Rare Earths reported FY25 results featuring record NdPr output and the first commercial heavy rare earths production outside China, alongside a $750 million equity raise to fund its ambitious Towards 2030 growth strategy.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Dimerix Limited reported a 22% reduction in its FY2025 loss to $13.25 million, driven by strong licensing revenues and advancing its pivotal Phase 3 clinical trial for DMX-200. The company secured new global partnerships valued at up to AU$1.4 billion, bolstering its cash reserves and commercial prospects.
Ada Torres
Ada Torres
28 Aug 2025
Lynas Rare Earths reported a 20% revenue increase in FY25 driven by higher NdPr sales, yet net profit fell sharply amid ramp-up costs and market challenges. The company completed key growth projects and unveiled its Towards 2030 strategy focused on downstream expansion.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Westgold Resources has transformed into a top five Australian gold producer following its merger with Karora Resources, delivering record gold production and declaring a 3-cent final dividend.
Maxwell Dee
Maxwell Dee
28 Aug 2025
South32 reported a robust turnaround in FY25 with a profit after tax of US$213 million and underlying earnings of US$666 million, driven by operational gains and strategic portfolio shifts. The company also advanced construction at its Hermosa project and maintained a strong balance sheet with net cash of US$123 million.
Maxwell Dee
Maxwell Dee
28 Aug 2025